Obesity Week
<ѻý class="page-description">The Obesity Societyѻý>Participants also had improved cardiometabolic measures with Epitomee device
Nearly all participants in SURMOUNT-1 avoided diabetes with the GLP-1/GIP receptor agonist
Diagnoses were also delayed the longer sugar was restricted
Messages about unethical industry practices came with less perceived weight stigma
Randomized trial achieves a substantial impact with personalized texting, goal-based feedback
These changes may contribute to an increased risk of obesity in kids, researcher says
Amount of weight lost by 6 months also played a role, according to a retrospective cohort study
At 12 months, there was an average weight loss of 16.2%, with results sustained up to 24 months
But even "regainers" still kept off most of the weight
Weight regainers had a similar incidence of mortality as weight-loss maintainers
Those on antidepressants lost an average 11% to 19% of body weight across the four STEP trials
Trial participants lost over a fifth of their body weight atop diet, exercise-induced losses
22.1% were found to have obesity in 2021, up from 19.8% in 2020
Quick-fix bars lead to extra caloric intake without really curbing appetite
-
Obesity Week: The Obesity Society
November 2024
-
EASD: European Association for the Study of Diabetes
September 2024
-
ENDO: The Endocrine Society
June 2024
-
AACE: American Association of Clinical Endocrinology
May 2024